Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation ConditioningBone Marrow TransplantationStem CellsGraft SurvivalGraft vs Host DiseaseHematopoietic Stem Cell MobilizationMultiple MyelomaCombined Modality TherapyCyclophosphamideAntigens, CD34Treatment OutcomeHematologic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsEtoposideGranulocyte Colony-Stimulating FactorLiver TransplantationTransplantation ChimeraHematopoietic Stem CellsTissue DonorsMesenchymal Stem Cell TransplantationCord Blood Stem Cell TransplantationCell TransplantationMyeloablative AgonistsBusulfanWhole-Body IrradiationKidney TransplantationRecurrenceEmbryonic Stem CellsHistocompatibility TestingRemission InductionMelphalanAdult Stem CellsRetrospective StudiesHistocompatibilityImmunosuppressive AgentsGraft vs Leukemia EffectLeukemiaTime FactorsTransplantation ImmunologyCell DifferentiationGraft vs Tumor EffectVidarabineSurvival AnalysisHeart TransplantationSurvival RateGraft RejectionTransplantation, IsogeneicT-LymphocytesLeukemia, Myeloid, AcutePluripotent Stem CellsDisease-Free SurvivalSalvage TherapyBlood Transfusion, AutologousHLA AntigensMesenchymal Stromal CellsHepatic Veno-Occlusive DiseaseLung TransplantationChimerismNeural Stem CellsLymphoma, Non-HodgkinStem Cell NicheFollow-Up StudiesMyelodysplastic SyndromesCells, CulturedHematologic DiseasesImmunosuppressionSiblingsLymphocyte DepletionBone Marrow CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaOrgan TransplantationInduced Pluripotent Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFlow CytometryAntilymphocyte SerumIslets of Langerhans TransplantationLymphocyte TransfusionCytomegalovirus InfectionsHematopoiesisHodgkin DiseaseAcute DiseaseCytarabineTransplantationAnemia, AplasticMice, Inbred C57BLMultipotent Stem CellsPrognosisCell SeparationLeukapheresisCell LineageCarmustineUnrelated DonorsCyclosporineBone MarrowLiving Donors